Diabetes Discourse
As the number of Americans living with diabetes continues to rise, staying up to date on the latest diabetes research is more essential than ever to help patients achieve glucose control. With Diabetes Discourse, you’ll hear from diabetes and endocrinology experts on emerging research, diagnostic and treatment strategies, and various elements that impact a patient’s disease course, including risk factors, vitamin and mineral supplementation, physical activity, and kidney disease.
Because when it comes to diabetes, glucose control is just the beginning.
16-30 of 219
Semaglutide Reduces CV Events in Non-Diabetic, Overweight Patients
Diabetes DiscourseSemaglutide Reduces CV Events in Non-Diabetic, Overweight Patients
Carol Wysham, MD
A. Michael Lincoff, MD
Overcoming Obesity: Insights from the SURMOUNT-4 Trial
Diabetes DiscourseOvercoming Obesity: Insights from the SURMOUNT-4 Trial
John Buse, MD, PhD
Louis J. Aronne, MD, FTOS
Strategies for Addressing Diabetes Stigma and Discrimination
Diabetes DiscourseStrategies for Addressing Diabetes Stigma and Discrimination
John Buse, MD, PhD
Mary de Groot, PhD
How the Artificial Pancreas Can Help Diabetic Patients
Diabetes DiscourseHow the Artificial Pancreas Can Help Diabetic Patients
Stuart Weinzimer, MD
Using CGMs and Insulin Pumps to Treat Pediatric Patients with T1D
Diabetes DiscourseUsing CGMs and Insulin Pumps to Treat Pediatric Patients with T1D
Stuart Weinzimer, MD
Challenging the Misconception That T1D Is a Childhood-Onset Disease
Diabetes DiscourseChallenging the Misconception That T1D Is a Childhood-Onset Disease
John Buse, MD, PhD
Michael Fang, PhD
- advertisement
Decoding Diabetes Diversity: A Study on Heterogeneity and Endotypes in T1D
Diabetes DiscourseDecoding Diabetes Diversity: A Study on Heterogeneity and Endotypes in T1D
John Buse, MD, PhD
Maria Jose Redondo, MD, PhD, MPH
Why Hybrid Closed-Loop Insulin Therapy Should Be Offered to Pregnant T1D Patients
Diabetes DiscourseWhy Hybrid Closed-Loop Insulin Therapy Should Be Offered to Pregnant T1D Patients
John Buse, MD, PhD
Helen Murphy, PhD
Discussing a T2D Medication That Could Reduce Insulin Needs in T1D
Diabetes DiscourseDiscussing a T2D Medication That Could Reduce Insulin Needs in T1D
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
David Selzer, MD
How Overnight Glucose Levels Impact Daily Activities in T1D Patients
Diabetes DiscourseHow Overnight Glucose Levels Impact Daily Activities in T1D Patients
John Buse, MD, PhD
Beth Pyatak, PhD, OTR/L
Breaking Down Biosimilar Insulins: A Look at the Regulatory Process and Impacts
Diabetes DiscourseBreaking Down Biosimilar Insulins: A Look at the Regulatory Process and Impacts
John Buse, MD, PhD
Simon Heller, MD
Educating Providers and Patients About Insulin Biosimilars
Diabetes DiscourseEducating Providers and Patients About Insulin Biosimilars
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Elizabeth Cook, PharmD, AE-C, BCACP, CDCES
- advertisement
How Ultra-Processed Foods Increase the Risk of Type 2 Diabetes
Diabetes DiscourseHow Ultra-Processed Foods Increase the Risk of Type 2 Diabetes
John Buse, MD, PhD
Jean-Philippe Drouin-Chartier, DtP, PhD
Recapping a Narrative Review on the Management of Chronic Kidney Disease in T2D
Diabetes DiscourseRecapping a Narrative Review on the Management of Chronic Kidney Disease in T2D
John Buse, MD, PhD
David Cherney, MD, PhD
The Impact of RADIANT: A Deep Dive into the Study
Diabetes DiscourseThe Impact of RADIANT: A Deep Dive into the Study
John Buse, MD, PhD
Louis Philipson, MD, PhD